Overweight, Obesity, and Late-Life Sarcopenia Among Men With Cardiovascular Disease, Israel

Miri Lutski1,2, Galit Weinstein3, David Tanne4,5

  • 1The Israel Center for Disease Control, Israel Ministry of Health, Tel Hashomer, Israel.

Preventing Chronic Disease
|December 28, 2020
PubMed

Insights

Obesity is linked to a higher risk of sarcopenia, the age-related loss of muscle mass and function, in men with cardiovascular disease. This suggests obesity may be a modifiable factor to consider in preventing sarcopenia.

Area of Science:

  • Gerontology
  • Cardiology
  • Nutritional Science

Background:

  • Sarcopenia, the age-related loss of muscle mass and function, is a growing concern in aging populations.
  • The relationship between obesity and sarcopenia, particularly in individuals with cardiovascular disease, remains under-researched.

Purpose of the Study:

  • To investigate the association between overweight, obesity, and sarcopenia in community-dwelling men with cardiovascular disease.
  • To determine if obesity is a risk factor for developing sarcopenia in this specific patient group.

Main Methods:

  • A subset of 337 men from the Bezafibrate Infarction Prevention trial underwent sarcopenia evaluation.
  • A multinomial logistic model was used to analyze the odds of probable sarcopenia and sarcopenia based on body mass index (BMI).

Main Results:

  • Sarcopenia was prevalent in 54.3% of participants with obesity (BMI ≥30.0) and 37.0% of overweight participants (25.0 ≤ BMI ≤29.9).
  • Overweight and obesity (BMI ≥25.0) were associated with significantly higher odds of probable sarcopenia (OR=3.27) and sarcopenia (OR=5.31) compared to normal weight (BMI <25.0).

Conclusions:

  • A positive association exists between obesity and late-life sarcopenia in men with cardiovascular disease.
  • Obesity may be an important, modifiable risk factor for sarcopenia in this population.
Abstract

Related Concept Videos

The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...